188 related articles for article (PubMed ID: 12751170)
1. [Role of glucagon-like peptide 1 (GLP-1) in regulation of insulin secretion].
Radosavljević T; Todorović V; Sikić B
Srp Arh Celok Lek; 2002; 130(11-12):416-9. PubMed ID: 12751170
[No Abstract] [Full Text] [Related]
2. Gastro-intestinal hormones GIP and GLP-1.
Kieffer TJ
Ann Endocrinol (Paris); 2004 Feb; 65(1):13-21. PubMed ID: 15122087
[No Abstract] [Full Text] [Related]
3. [GLP-1 and the control of insulin secretion].
Thorens B
Journ Annu Diabetol Hotel Dieu; 1994; ():33-46. PubMed ID: 8051830
[No Abstract] [Full Text] [Related]
4. Incretin hormones and insulin secretion.
Ahrén B; Gromada J; Schmitz O
Horm Metab Res; 2004; 36(11-12):733-4. PubMed ID: 15655700
[No Abstract] [Full Text] [Related]
5. [GIP and GLP-1: multiplicity of regulator mechanisms for insulin secretion].
Thorens B
Journ Annu Diabetol Hotel Dieu; 2004; ():111-25. PubMed ID: 15259310
[No Abstract] [Full Text] [Related]
6. [Glucagon-like peptide-1 (GLP-1) receptor].
Taminato T
Nihon Rinsho; 2002 Jul; 60 Suppl 7():535-41. PubMed ID: 12238094
[No Abstract] [Full Text] [Related]
7. Is glucagon-like peptide 1 an incretin hormone?
Nauck MA
Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
[TBL] [Abstract][Full Text] [Related]
8. GLP-1 and the gut.
Thompson DG
Gut; 2000 May; 46(5):591. PubMed ID: 10764696
[No Abstract] [Full Text] [Related]
9. [Incretin research in the development of new strategies of diabetes therapy].
Göke B; Göke R; Fehmann HC; Arnold R
Internist (Berl); 1995 Apr; 36(4):343-9. PubMed ID: 7775082
[No Abstract] [Full Text] [Related]
10. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes.
Ahrén B
Bioessays; 1998 Aug; 20(8):642-51. PubMed ID: 9780839
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin.
Fehmann HC; Göke R; Göke B
Mol Cell Endocrinol; 1992 May; 85(1-2):C39-44. PubMed ID: 1382025
[TBL] [Abstract][Full Text] [Related]
12. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion.
MacDonald PE; El-Kholy W; Riedel MJ; Salapatek AM; Light PE; Wheeler MB
Diabetes; 2002 Dec; 51 Suppl 3():S434-42. PubMed ID: 12475787
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 structure, function and potential use for NIDDM.
Gefel D; Barg Y; Zimlichman R
Isr J Med Sci; 1997 Oct; 33(10):690-5. PubMed ID: 9397146
[TBL] [Abstract][Full Text] [Related]
14. ["Glucagon-like peptide I": a therapeutic alternative for diabetes mellitus?].
Fehmann HC; Göke B
Dtsch Med Wochenschr; 1994 Feb; 119(8):275-9. PubMed ID: 8112212
[No Abstract] [Full Text] [Related]
15. [Gluco-incretin hormones in insulin secretion and diabetes].
Thorens B
Med Sci (Paris); 2003; 19(8-9):860-3. PubMed ID: 14593618
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism underlying glucagon-like peptide 1 induced calcium mobilization from internal stores in insulin-secreting beta TC3 cells.
Gromada J; Rorsman P
Acta Physiol Scand; 1996 Jul; 157(3):349-51. PubMed ID: 8830891
[No Abstract] [Full Text] [Related]
17. Overview of incretin hormones.
Efendic S; Portwood N
Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
[TBL] [Abstract][Full Text] [Related]
18. The incretins--outdated terminology in man?
Edwards CM; Bloom SR
Diabetologia; 1999 Sep; 42(9):1148-9. PubMed ID: 10447529
[No Abstract] [Full Text] [Related]
19. Glucagon-like peptide-1 and control of insulin secretion.
Thorens B
Diabete Metab; 1995 Dec; 21(5):311-8. PubMed ID: 8586147
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM.
Thorens B; Waeber G
Diabetes; 1993 Sep; 42(9):1219-25. PubMed ID: 8349031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
